Health insurer Aetna Inc (AET.N) said it would provide coverage for diet pills of Vivus Inc (VVUS.O) and Arena Pharmaceuticals Inc (ARNA.O), sending the obesity drugmakers' shares up. The decision by the third-largest health insurer to provide coverage ...
The Cardinals have had big runs in each of the past two seasons, their miraculous comeback in 2011 from being 10� games out of a playoff spot in late August to winning the World Series, then gaining the final wild-card slot this season.
Shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN) and VIVUS (NASDAQ: VVUS) grew somewhat between the October 15 and October 31 settlement dates.
Nov. 28 (Bloomberg) -- An antibody discovered by Amgen Inc. researchers reduces weight and increases glucose tolerance in monkeys, according to a study, potentially opening up a new approach for treating obesity and diabetes in humans.
Right now only two entries have received FDA approval - Qysmia (formerly called Qnexa) from Vivus and Belviq from rival Arena Pharmaceuticals (NASDAQ:ARNA). Back in February the ... approved at this time. The company is going to appeal the decision.